- For over 45 years Anthony Nolan has recruited potential stem cell donors to their register – people who are willing to donate their cells to someone in need of a lifesaving stem…
- Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and…
- Ensuring care has the patient at the centre is a key aim for the NHS and something we’re particularly interested in at Anthony Nolan. Our post-transplant care pathway sets out one…
- Here, Anthony Nolan’s Chief Executive, Henny Braund, gives an overview of current and emerging treatments for blood cancer and the developments needed to give patients the best…
- Through the Anthony Nolan Cell & Gene Therapy Service’s provision of cellular material to cell and gene therapy researchers, we are familiar with industry standards and…
- The NHS Long-Term Plan commits to exploring new payment models to ensure that patients are able to receive the right care, in the right place, at the right time. The COVID-19…
- Since our research institute opened in 1996, We have made many scientific discoveries and established key initiatives that have transformed how transplants are performed world-…
- The Anthony Nolan Research Institute One of the greatest challenges in stem cell transplantation is understanding why some transplants are unsuccessful – even if the…
- Our statement Anthony Nolan helps four people in need of a transplant a day, giving more people a second chance at life. But the charity won’t stop until all patients…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.